Cloning and characterization of the cDNA coding for a polymyositis- scleroderma overlap syndrome-related nucleolar 100-kD protein by unknown
Cloning and Characterization of the cDNA  Coding 
for a  Polymyositis-Scleroderma  Overlap 
Syndrome-related  Nucleolar  100-kD Protein 
By Martin Blfithner and Friedlinde A. Bautz 
From the Institute of Molecular Genetics, University of Heidelberg, W-6900 Heidelberg, 
Germany 
Summary 
About 50%  of patients with the polymyositis-scleroderma overlap syndrome are reported to 
have  autoantibodies  to  a  nucleolar particle  termed PM/Scl.  The particle consists  of several 
polypeptides of which two proteins of 75 and 100 kD have been identified as the major antigenic 
components. Here we report on the cDNA cloning and partial epitope mapping of the 100-kD 
autoantigen from human placenta and HeLa ~, gtll libraries.  The deduced amino acid sequence 
encodes a protein of 885 amino acid residues with a molecular mass of 100.8 kD. Rabbit antibodies 
raised against a recombinant protein fragment reacted in immunofluorescence  and immunoblotting 
in the same manner as human autoantibodies directed against the nucleolar 100-kD protein. 
Sequence analysis  shows  close homology to  a  consensus  sequence of 12  amino  acids  from 
serine/threonine kinases,  suggesting a possible function for this autoantigen. A major antigenic 
region is found to be located within the NHz-terminal third of the polypeptide. 
A  variety of antinucleolar autoantibodies  have been reported 
to occur in sera from patients suffering from systemic 
sclerosis (sderoderma). The antigens reacting with these pa- 
tient sera are RNA polymerase I, DNA topoisomerase I, fibril- 
hrin, and a so far unidentified nucleolar partide that is precipi- 
tated by a high percentage of sera from patients with the 
polymyositis-scleroderma (PM/SCl) 1 overlap syndrome. An- 
tibodies to the PM/Sd antigen are found predominantly in 
sera from patients with dinical features of scleroderma (3%) 
and polymyositis (8%). A significantly higher incidence (50%) 
of PM/SCl autoantibodies was observed for patients with the 
PM/Scl overlap syndrome (1). Indirect immunofluorescence 
studies have shown that the PM/Scl autoantibodies give strong 
staining of the cell nudeolus with some weak staining of 
the nucleoplasm (2-4).  Further studies indicated that  the 
PM/Scl antigen is localized in the granular component of 
the nucleolus (3,  5). 
By immunoprecipitation it could be shown that the PM/Scl 
partide consists of "~11-16 polypeptides with apparent mo- 
lecular masses ranging from 20 to 100 kD (3, 4, 6, 7). Al- 
though no RNA was found to be precipitated with the par- 
tide, its location in the granular component of the nucleolus 
suggests its involvement in ribosome maturation (3, 8). In 
immunoblots most of the PM/SCl sera were found to react 
with polypeptides of 75 and 100 kD. Since no crossreactivity 
for the two immunoreactive peptides could be observed with 
1  Abbreviation used in this paper: PM/Scl,  polymyositis-scleroderma. 
a~nity-purified antibodies, it was assumed that they repre- 
sent two distinct protein entities (7). 
Recently, Alderuccio et al.  (8) succeeded in cloning and 
sequencing of the human cDNA encoding the 75-kD au- 
toantigen of the PM-Sd complex. In this study we report 
the application of af~nity-purified antibodies from the PM/Scl 
100-kD protein in the cloning and sequencing of the human 
cDNA encoding the 100-kD autoantigen. We have cloned 
the full-length cDNA of 2,797 bp coding for a polypeptide 
of 885 amino acids with a deduced molecular mass of 100.8 kD. 
Materials and Methods 
Patients and Sera.  15 sera from patients suffering from PM/Scl 
overlap syndrome were kindly provided by Dr. E. Genth (Rheu- 
maklinik, Aachen, Germany). Two sera from patients with other 
autoantibody  profiles and a normal human serum were used as 
controls. 
Preparation of Nucleolar Extracts.  Nuclei of 1.5  x  109 HeLa $3 
cells were prepared as described previously (9). All buffers contained 
1 mM PMSF and all steps were done at 4~  Pelleted and washed 
nuclei were sonicated in 15 ml buffer I (250 mM sucrose, 10 mM 
Tris/C1, pH 7.4, 1 mM MgC12) with five 5-s pulses at 45 W using 
a sonifier (Bronson Sonic Power Co., Danbury, CT). The suspen- 
sion was centrifuged through a sucrose cushion (880 mM sucrose, 
10 mM Tris/Cl, pH 7.4) at 1,000g and 4~  for 30 min. The super- 
natant was discarded, and the nucleoli were resuspended in 4 ml 
buffer  II  (880 mM sucrose, 10 mM Tris/C1, pH  7.4,  1 mM 
MgC12) and sonicated as described above. Disrupted nudeoli were 
pelleted at 4,000 g and 4~  for 20 min and resuspended in 2 ml 
Laemmli buffer. 
973  J.  Exp. Med.  ￿9  The Rockefeller University Press ￿9 0022-1007/92/10/0973/08 $2.00 
Volume 176  October 1992  973-980 Screening of cDNA  Libraries with Antibody Probes.  Affinity- 
purified anti-100-kD antibodies  from serum A3 were used to screen 
a  total  of 2.5  x  10  s recombinant phages from  HeLa cDNA 
libraries constructed with X gtll (10) (Genofit, Heidelberg, Ger- 
many). Two nitrocellulose  sheets  were used on each plate. The first 
was probed with undiluted  affinity-purified antibodies and the 
second with patient's serum A3 (1:800 in TBS). Only plaques that 
were positive on both sheets were further purified. 
Screening of eDNA Libraries with DNA Probes.  After EcoRI 
digestion and separation  by agarose  gd electrophoresis,  cDNA frag- 
ments were purified using the Geneclean  kit (Dianova, Hamburg, 
Germany). Fragments were labded with Digoxigenin (Boehringer, 
Mannheim, Germany) and used as hybridization probes (following 
manufacturer's instructions) on a total of 2.5  x  106 recombinant 
phages from human placenta cDNA libraries in X gtll (Genofit). 
DNA Sequencing.  DNA fragments were subcloned into Blue- 
script  SK  or  KS  vector  (Stratagene,  Heidelberg, Germany), 
M13mp18, and M13mp19. DNA sequencing was carried out ac- 
cording to the dideoxy technique of Sanger et al. (11) using syn- 
thetic oligonucleotide  primers. The nudeotide sequences were ana- 
lyzed with PC/Gene  TM  software (Intelligenetics, Inc., Mountain 
View, CA). 
Polyroerose Chain Reaction.  DNA fragments for partial epitope 
mapping were generated by PCR (12). Primers used carried either 
a synthetic BamHI or BglII site and a three-nucleotide clamp at 
their  5'  ends. Asymmetric PCR was  performed according to 
McCabe (13) using a molar ratio of primers of 75:1. 
Analysis of the roRNA 5' End by PCR.  The 5' sequence was 
analyzed  by reverse transcription of HeLa $3 mRNA with a gene- 
specific primer followed  by tailing and PCR as described  previously 
(14). The resulting DNA fragment was amplified again by asym- 
metric PCIL (13). The single-stranded  DNA was sequenced  by the 
chain termination method using a gene-specific antisense primer 
ranging from nucleotide 279 to 263. 
Expression of Recorobinant Proteins.  The DNA fragment from 
done A16/2 was subcloned from pBhescript  into pUR291 and 
the corresponding fusion protein was expressed as described (15). 
For epitope mapping PCR-generated  fragments  were subcloned  into 
the BglII site of pDS56-6His vector (16). Expression  of the peptide 
fragments was induced with 2 mM isopropyl-/3-D-thiogalacto- 
pyranoside (JFIG) and purification of the peptides was performed 
on Ni  2§  chelate cohmns as described (16). 
Irorounoblotting and A.~nity  Purification of Antibodies.  Protein 
samples were subjected to dectrophoresis on SDS-polyacrylamide 
gels (12.5, 15, or 17.5%, respectively)  (17) and electroblotted onto 
nitrocellulose (18). The blots were blocked with 40% horse serum 
for 90 min and probed with the appropriate serum dilution. Bound 
antibodies were visualized  with a second  antibody (goat anti-human 
IgG(H+L) or goat anti-rabbit  IgG(H+L)) (Dianova) coupled to 
alkaline  phosphatase. Affinity  purification  of  bound antibodies  from 
nitrocellulose sheets was performed by the pH shock method as 
described by Smith and Fisher (19) followed  by concentration with 
Centricon-30 microconcentrators (Amicon Corp., Danvers, MA). 
Indirect Irorounofluorescence.  Cytoimmunofluorescence  was per- 
formed on Hep2 cells grown on cover slips and fixed  by methanol 
and acetone  as described (20). They were then incubated  either with 
anti-PM/Scl serum, afffinity-purified  anti-PM/Scl antibodies, or 
affinity-purified  rabbit antibodies in PBS, pH 7.4, in appropriate 
dilutions, and subsequently  with FITC-conjugated  goat anti-human 
IgG (Dianova) or goat anti-rabbit  IgG in the same buffer. Im- 
munofluorescence was observed (Axioskop, Plan-Neofluar 40x, 
equipped with epifluorescence  optics; Zeiss, Oberkochen, Germany) 
and photographed with IIford  (Mobberly Cheshire, England) HP5 
film. 
Immunization  of  Rabbits  with  a  Purified Protein Fragment. 
New Zealand white rabbits were bled before immunization and 
then immunized subcutaneous  in the neck with FPLC-purified  pep- 
tide fragment A (150/~g) in ABM-S (Linaris,  Bettingen, Germany) 
as adjuvant. Second and third immunizations were given after 15 
and 27 d with 150/zg antigen each. Rabbits were bled after 40 d, 
and immunoreactivity was tested in indirect immunofluorescence 
and immunoblotting. 
Results 
Immunoblotting  Analysis  of  PM/$cl  Autoantisera.  The 
PM/Scl autoantisera used in this study revealed immunoreac- 
tivity with two major nucleolar antigens with molecular 
masses of 75 and 100 kD, as determined by immunoblot anal- 
ysis on nucleolar extracts (Fig.  1, lanes a and b). Occasion- 
ally,  an additional reactivity was observed with an 80-kD 
nucleolar antigen (data not shown). These data are in good 
agreement with previously published results (3,  8). 
Isolation and Characterization of  a Partial cDNA Clone.  An- 
tibodies were aFfinity  purified from the nucleolar  lO0-kD pro- 
tein and used to screen 2.5  x  10  s recombinants from a HeLa 
X gtll expression library. After plaque purification four clones 
were obtained that on further investigation were shown to 
be identical. The respective/~-galactosidase fusion proteins 
had a molecular mass of 135 kD, as determined in SDS-PAGE 
(data not shown). Therefore, the cDNAs encoded a peptide 
fragment  of ,,020 kD.  All  four  fusion proteins,  but  not 
/~-galactosidase alone,  reacted with anti-PM/Sd serum A3 
in  immunoblot analysis  (data not  shown).  Expression  in 
Figure 1.  Immunoreactivities  of selected  PM/Scl patient sera  with the 
nucleolar 100-kD protein. Immunoblots  of HeLa  nucleolar  extracts sepa- 
rated on 12.5% SDS-polyacrylamide  gels were probed. (Lane  a) PM/Scl 
patient serum A2; (lane b) PM/Scl patient serum A3; (lanes c and d) a 
normal human  and a primary  biliary  cirrhosis (PBC) patient  serum  as con- 
trols. The 100- and 75-kD nucleolar  proteins of the PM/Scl complex  are 
indicated. 
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of a HeLa nucleolar extract sepa- 
rated  on  a  12.5 SDS-polyacryl- 
amide gal. (Lane a) Antibodies of 
patient serum A3 affinity purified 
from/5-galactosidase;  (lane b) pa- 
tient serum A3. The fusion pro- 
tein from clone A16/2 was used 
to affinity purify antibodies from 
patient  serum  A3  (lane  c)  or 
normal  human  serum  (lane  d). 
The position of the 100-kD  nu- 
deolar protein is indicated. 
pUR291 and further immunoblotting analysis of the respec- 
tive fl-galactosidase fusion protein confirmed an open reading 
frame as determined by sequence analysis (nudeotide posi- 
tion 235-745). Affinity-purified antibodies from the fusion 
protein were tested by immunoblotting and indirect im- 
munofluorescence. In immunoblots only the nucleolar 100-kD 
protein is recognized by the affinity-purified antibodies (Fig. 
2, lane c). Indirect immunofluorescence studies with these 
antibodies showed identical nucleolar staining on Hep2 cells 
as affinity-purified lO0-kD antibodies (Fig. 3, a and b). These 
results confirm that our cDNA clone codes for a fragment 
of the 100-kD PM/Scl antigen. All six PM/Sd sera tested 
reacted with this fusion protein in immunoblots. No reac- 
tion was observed with a human control serum (data  not 
shown), suggesting that we have cloned a major antigenic 
region of the lO0-kD PM/Scl antigen. 
Isolation  and  Characterization  of  a  Full-Length  cDNA 
Clone  The cDNA fragment of clone A16/2 was labeled with 
digoxigenin and used as a hybridization probe to isolate  a 
full-length cDNA from a human placenta cDNA library in 
)x gt11. Screening of 2.5  x  106 recombinants yielded three 
clones with cDNA inserts of the expected sizes. The corre- 
sponding  cDNAs  were  subcloned  into  M13mp18  and 
M13mp19 and sequenced. The sequencing strategy is shown 
in Fig. 4 a. One done (H 2/8) was obtained that presumably 
encoded the full-length cDNA of the 100-kD  PM/Scl an- 
tigen ranging from nucleotide -1 to 2797.  The nucleotide 
sequence and the deduced amino acid sequence are shown 
in Fig. 4 b. A long open reading frame was found, ranging 
from position I to 2655, that encodes 885 amino acids with 
a predicted molecular mass of 100.8 kD, which corresponds 
well to the observed molecular mass of 100 kD of the nucleolar 
protein. The termination codon TAG is at position 2656. A 
potential polyadenylation signal (ATTAAA) is located at po- 
sition 2737, followed by the poly(A) tail starting at position 
2753. 
Determination of the 5' End of the mRNA.  To determine 
the 5' end of the transcription product, mRNA from HeLa 
$3 cells was isolated  and cDNA was synthesized, followed 
by tailing,  PCR,  and  sequencing of the resulting single- 
stranded  DNA  fragment,  as  described  in  Materials  and 
Methods. The obtained sequence exactly matched the sequence 
of clone H2/8 and showed 36 additional nucleotides from 
position -37 to  -1 (Fig. 4 b). No termination signal was 
observed preceding the putative start codon ATG at position 
+ 1. However, the sequence surrounding the start codon ATG 
at position + 1 matches Kozak sequence elements (21). These 
results,  together with the fact that no longer cDNA could 
be isolated from the cDNA libraries,  indicate that we have 
cloned the fuU-length cDNA of the human 100-kD PM/Scl 
autoantigen. 
Figure 3.  Indirect immunofluorescence  on Hep2 cells with affinity-purified anti-PM/Scl 100-kD antibodies from patient serum A3. Antibodies were 
ehted from the nucleolar 100-kD protein bound to nitrocellulose (a) and from the fusion protein of done A16/2 (b). Bound antibodies were visualized 
with a FITC-coupled goat anti-human IgG antibody, and immunofluorescence  was observed  by epifluorescence  optics (x 750). 
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-37  b  ACAAGCTCTCGCGAGACGAGCCGTGCAGGOTGAAAAA 
l  ATGGCGCCACCCAG  TACCCGGGAGCCCAGGGTCCTGTCGGCGACCAGCGCA.~CCAAATCCCa~CGC~GAGAT~TGCTGCCAGGC  TTCCC  GC~  CG  C  C~CTTTG  TC~/~GTI'TGCTC  TTGGG  TC  C  G  TG  G  TGGCA 
I  H  A  P  P  S  T  R  E  P  R  V  L  S  k  T  S  A  T  g  S  D  G  E  M  V  L  P  G  F  P  D  A  0  S  F  V  g  F  A  L  G  S  V  V  A 
136  G~CACC~GCATC~GGG~GCC~ACCACAGTTTGGC~GTA~TTTTTACC~GTT~CTGGC~TCC~GCAT~TG~GAAACA~G~G~T~GTG~T~T~T~AG~AC 
VTKASGGLPQFGDEYDFYRSFPG~QAFCETQGORLLQCMSRVMQY 
271  ~TGGG~G~CGCAGC~CATT~G~TCG~GT~GT~CT~GCT~C~GT~T~ACTAG~TGC~TGATGT~TTCT~GTGGGTAT~TACTG~T~GcCTCAGGTGT~C 
91  HGCRSNIKDRSKVTELEDKFDLLVOANDVILERVGILLDEASGVN 
406  AAGAATC~CAGCC  TGTCC TCCC TGCC GGCTTGCAGGTCCCCA~CGGTAG  TG  TCCAGCTGGAACCGTA~AGCAGAATATGGC~GCA~TCTGA~CTTTCCGGCTGCTTCATGCA~TATC 
136  K  N  Q  Q  P  V  L  P  A  G  L  Q  V  P  K  T  V  V  S  S  W N  R  K  A  A  E  Y  G  K  g  A  g  $  E  T  F  R  L  L  H  A  K  N  I 
541  ATcC~CcTCAGCTC~GTTTC~TT~C~TTCC~cACACCATTTCT~CCT~TCTTcAT~CCc~TGCT~CcTcTCCCTC~GcTCTCTCT~G~G~G~C~CCcA~G 
~8!  IRPQLKFREKIONSNTPFLPKIFIKPNAQKPLPQALSKERRERPQ 
676  ~TCGTCcT~G~c~GGACGTCCCCCCTG~CTGGcT~T~CATCCATCAGCA~CC~GCA~G~CATG~GcAcAT~C~AT~TAT~CT~TCAC~ACcC~G~TGCA 
226  DRPEDLDVPPALADFIHQQRTQQVEQDMFAHPYQYELNHFTPADA 
811  ~TG~T~GCCAC~CCCCAG~ATA~CC~A~AG~CCATGC~T~CATATC~TCCCTG~C~C~TG~C~C~TC~TTGT~G~GCA~CTTG~G 
271  VLQKPQPQLYRPIEETPCHFISSLOELVELNEKLLNCQEFAVDLE 
g46  ~C~CTCT~ACAG~GCTT~CT~G~CT~CCT~c~T~T~C~kATTTCTACTCG~C~T~CACC~TC~GCTTc~GT~TGTACATTCTC~T~GCCTC~CCCAGCC 
316  HHSYRS~LGLTCLMQISTRTEDFIIDTLELRSDMYILNESLTDPA 
I081  ATCGTTMGGTCTTTCAT~T~T~TTC~CATA~TGGCTACA~CTT?GGGTTGTATGTAGTAA~C~TGT~TA~T~T~G~C~GCACGCCTTCTTMCCTGGG~GGCACT~CTC~TC~T 
~61  IVK~FHGAOSDIE~LQKDFGLYVV~MFDTHQAARLLNLGRHSLDH 
1216  ~CCTC.~VV~CTCT~TGC~CGTG~CTC~A~/V~TAT~T~GCT~TTG~TACGCCCTC~CCC~G~TGCT~TACGC~T~CC~TTACCTGCTATATA~CTAT~C~ 
406  LLKLYCgVDSNKQYQLAD~R~RPLPEEMLSYARODTHYLLYIYOK 
~i  AT~GGCTG~TGTG~GG~GGGCAGC~CGT~TG~GGTGG~GTGG~CG~CATC~TC~TTCATC~C~&ICT~T~TCCT~C~CTCTAT 
~I  HRLEMWERGMGQPVQLQ~VWQRSROICLKKFIKPIFTOESYLELY 
1621 
541 
566 
I~91 
2026 
6/6 
2161 
721 
2296 
/66 
2431 
611 
2566 
B56 
2701 
~KQKKHLNTQQLTA~LLFAWROKIARREDESYGYVLPNHMMLKI 
G~TG~CTG~CT~G~T~GCAT~A~GC~GCTG~CCCAGTACC~GTGCGGCAG~T~T~TC~GCCC~I~CCCTGCT~GTCT~ 
AEELPKEPQ~IIACCNPVPPLVR~QINEMHLLIOQAREMPLLRSE 
~GC~GT~CG~CCGCTGC~CA~T~Ga~/~GATTG~TG~~l7E~CCT~G~TGG~TATC~A~C~GTG~TCT~TGCCA 
YAAGV~K$GPLPSAERLENVLFGPNOCSNAPPOGYPIIPTSGSVP 
GR~GCC~CC~TGJV&A~4~T~AC~TG~CT~T~G~C~&~J&~(CTGI~TCACG~A~T~T~T~T~IAJV&~A~GTC~TT~A 
VQKQASLFPDEKEONLLGTTC~IAIAW~TLFMEPSAEOSKKGPLT 
~TTG~CC~C~T~TG~TCCTTTGA~TCCAT~AG~TGT~CTGCCCT~I~TCC~TC~T~G~C~G~C~TC~TC~C~T~TAT~TC 
VAQKKAQNIMESFEMPFRMFLPSLGHRAPVSQAAKFDPSTRIYEI 
~CC~TTGG~CTG~CAGGTA~GTACA~GACTCT~GCTGTC~GA~TGA~CTGCC~AGGC~G~GCGTGC~GCTGCAGC~GGCCATC 
SNRWKLAQVQVQKDSKEAVKKKAAEQTAAREQAKEACKAAAEQAI 
~C~GT~C~GCA~TCGTGCTAGA~TGCTG~A~MCMGC~G~C~A~A~CA~C~G~CTC~T~C~GCC~C~GCCA 
SVRQQVVLENAAKKRERATSDPRTTEQKQEKKRLKISKKPKDPEP 
~AGA~GAGTTTAC~CTT~TA~C~TC~CTTC~G~CTTTTGCTGG~TCC~TTTCTT~TCAGTTT~TC~T~GACCCCGTCTGGCMG~TGCATTGCAGCC 
PEKEFTPYOYSQSOFKAFAGNSKSKVSSQFDPNKQTPSGKKCIAA 
A~TT~TCGGT~G~C~TGT~CTTTCC~TGG~GTCA~CA~GG~TTCAGGT~CT~CAC~lCCTG~CGT~CGCC~TG~CCG~GCACC~T 
KKIKQSVGNKSMSFPTGKSDRGFRYNWPQR 
GCTGGTGCTGCTTTTGTA~TACATATTTTTA~CCATTA~TTCTTCCTG~ 
Figure  4.  cDNA  sequence  of 
done H2/8 and deduced amino acid 
sequence  of the encoded nucleolar 
100-kD  PM/Scl  protein.  (a)  Se- 
quencing  strategy  of clone H2/8. 
Sequencing  was carried out by the 
Sanger dideoxy technique using syn- 
thetic oligonucleotide primers (see 
Materials and Methods). (b) cDNA 
sequence  of  the  100-kD  PM/Sd 
clone H2/8.  The  deduced  amino 
acid sequence is displayed below the 
DNA sequence.  The start and ter- 
mination codons and the potential 
polyadenylation  signal (ATTAAA) 
are underlined.  Double-underlined 
sequences show the additional eDNA 
sequence  obtained by reverse tran- 
scription followed by tailing, PCR, 
and  direct  sequencing  of the  re- 
sulting single-stranded  PCR prod- 
uct  (see Materials  and  Methods). 
The sequence data are available from 
the EMBL Data bank under acces- 
sion number X66113. Table  1.  Amino  Acid Sequence Comparison of the lO0-kD PM/Scl Protein and Serine/Threonine Kinase Sequences  (22-29) 
Amino acid 
residue  Reference  Sequence 
Human PM/Scl  100-kD protein 
Human B-raf 
Drosophila D-raf 
Human C-tar 
Avian retro  virus MH2 V-mil 
Human A-raf-1 
Yeast cAMP-dependent protein  kinase, type 1 
Protein kinase C, fi rat 
Protein  kinase C,  ~" rat 
Potential consensus sequence 
170-187  E T F R L 
123-141  22  Q GMD Y 
461-478  23  Q GMD Y 
454-471  24  Q GMD Y 
187-198  25  Q G MD Y 
415-432  26  Q GMD Y 
196-213  27  L A L E Y 
457-472  28  C G L Q F 
362-379  29  I A L N F 
LHAKNI  IIRpQ~-'-K 
LHAKS  [  IHRDLK 
LHAKNI  IHRDLK 
LHAKNI  IHRDMK 
LHAKNI  IHRDMK 
LHAKNI  IHRDLK 
LHSKS  I  IYRDLK 
LHGKGI  IYRDLK 
LHERGI  IYRDLK 
LHAKNI  IHRDLK 
F 
S 
S 
S 
S 
S 
P 
L 
L 
Relevant segments  of the serine/threonine  kinase  sequences  are compared  with the corresponding  segment  of the nucleolar 100-kD PM/Scl protein. 
The amino acid positions are shown together  with the respective sequences. The regions representing the potential consensus sequence are boxed. 
The potential consensus sequence itself  is displayed  below the aligned sequences. 
Computer Search for Sequence Similarities of the PM/Scl 100 
Antigen.  The deduced amino acid sequence of the 100-kD 
protein was used to search the EMBL data bank for homolo- 
gous  sequences.  No  close  similarity was  found with  any 
reported sequence, implying that we have cloned a new and 
unique cDNA. However, a stretch of  9 of 12 consecutive amino 
acids (amino acid residues  175-186)  could be found to show 
identity with the consensus sequence of a series of proteins, 
all belonging to the serine/threonine kinase family (22-29). 
All together, 28 serine/threonine kinases were found to con- 
tain this or a related subsequence.  Table I shows a computer- 
based alignment of some representatives  of this group of pro- 
teins together with the corresponding amino acid sequence 
of the 100-kD PM/Scl autoantigen. Further analysis of the 
cDNA sequence by the PC/Gene  TM program showed 16 poten- 
tial phosphorylation sites for serine/threonine kinases on our 
deduced amino acid sequence, in contrast to only two poten- 
tial phosphorylation sites for tyrosine kinases. 
Expression of Defined eDNA Fragments and Partial Epitope 
Mapping.  For partial epitope mapping, DNA fragments were 
prepared by PCR using synthetic oligonucleotide primers as 
described in Materials and Methods (Fig. 5 a). The resulting 
cDNA  fragments  were  subcloned  into  the  BgllI  site  of 
pDS56-6His vector. Expression and purification of the cor- 
responding peptide fragments were performed as described 
in Materials and Methods. The reactivities of the PM/Scl sera 
with the various peptide fragments were determined by im- 
munoblots (Fig. 5 b) and are summarized in Table 2. All sera 
recognizing the 100-kD nucleolar protein react with the pep- 
tide fragments A, B, and C, indicating that at least one major 
antigenic determinant is localized between amino acid residues 
153 and 324.  Peptide fragments E and F are recognized by 
4 of 15 sera. This indicates that at least one minor antigenic 
determinant is localized between amino acid residues 492 and 
703. Peptide fragment D is not recognized by any of the sera. 
The relative positions of the fragments and the antigenic de- 
terminants are shown in Fig.  6. 
Rabbit Antibody to a Recombinant  Peptide.  The peptide frag- 
ment A (Figs.  5 and 6, lane a) was used to raise antibodies 
in rabbits as described in Materials and Methods. The resulting 
antibodies were tested in indirect immunofluorescence and 
in immunoblots. Antibodies affinity purified from peptide 
fragment A  were used for further studies. 
In indirect immunofluorescence on Hep2 cells, nucleolar 
staining could be observed (Fig.  7 a).  In immunoblots the 
affinity-purified rabbit antibodies reacted with the 100-kD 
nucleolar protein (data not shown). These findings give fur- 
ther support to the authenticity of our cloned cDNA to code 
for the 100-kD  PM/Sd autoantigen. 
Figure 5.  Determination  of antigenic regions  by immunoblotting  of 
the expressed  peptide fragments  of the 100-kD PM/Scl  protein. (a) Exact 
amino acid  positions of the peptide fragments  tested. (b) R~Fresentative 
immunoblot of the peptide fragments A-F using patient serum A14. 
977  BlQthner  and Bautz Table  2.  Summary of the Reactivities in Immunoblot Analysis of the PM/Scl Patient and Control Sera with the Expressed Peptide 
Fragments of the Nucleolar lO0-kD PM/Scl Protein 
Fragment 
Serum*  A  B  C  D  E  F  100  kD* 
A1  +  +  +  -  _  _  + 
A2  ++  ++  ++  -  -  _  ++ 
A3  +  +  +  +  +  +  -  (+)  (+)  +  + 
A4  +  +  +  -  (+)  _  + 
A6  ++  +  ++  -  +  +  + 
A7  ++  +  ++  -  +  +  + 
A8  +  +  +  -  -  -  + 
A9  ++  ++  ++  -  ++  ++  ++ 
A10  +  +  +  +  -  -  -  + 
A12  +  +  +  -  -  -  + 
A13  +  +  +  +  +  +  -  +  +  +  + 
A14  +  +  +  +  +  +  -  -  -  + 
L  ++  +  +  -  -  -  + 
H  +  +  +  -  -  -  + 
K  +  +  +  -  -  +  + 
NHSS  ....... 
PBC  I s  ....... 
PBC  IIS  ....... 
* Sera A1-A14, L, H, and K are PM/Scl patient sera; immunoreactivities: +  +, strong positive reaction;  +, positive reaction; ( + ), weak reaction; 
-,  no reaction. 
t  100 kD  is the nucleolar 100-kD PM/Scl protein. 
$ Control sera: NHS is a normal human serum (Blutbank, Heidelberg, Germany); PBC I and II are sera from patients with primary biliary cirrhosis. 
peptide  fragment 
A 
B 
C 
D 
E 
F 
amino  acid  residues 
0  100  200  800  400  500  600  700  800 
]  I  I  I  I  I  I  I 
I 
I 
I 
major antigenic  minor antigenic 
determinant  determinant 
Figure 6.  Distribution of antigenic regions on the primary sequence 
of the nucleolar 100-kD PM/Scl protein, cDNA fragments were prepared 
by PCK and subcloned into the expression vector pDS56-6His. The black 
area  represents the major antigenic determinant(s), and the grey area 
Discussion 
The aim of the work  reported here was  the cloning and 
characterization of the eDNA  coding for the nucleolar 100-kD 
protein,  which  was  found  to  be  the  major  antigen recog- 
nized by  PM/Scl  autoantisera  (4). 
We have cloned the full-length eDNA  of this protein with 
2797 bp coding for 885 amino acid residues with a deduced 
molecular mass of 100.8 kD. A  comparison with the recently 
published eDNA  sequence of the nucleolar  75-kD  PM/Scl 
protein (8) showed no homology  to the cDNA  sequence of 
the 100-kD PM/Scl protein. This result confirms our previous 
observation that a~nity-purified 100 kD  autoantibodies do 
not  crossreact  with  the  75-kD  nucleolar  protein  and  vice 
versa (7). 
The sequence identity in 9  of 12 consecutive amino acids 
with  several proteins belonging to  the serine/threonine ki- 
nase  family  indicates  a  possible  function  for  the  nucleolar 
100-kD protein (Table 1).  As protein kinases are known  to 
be involved in many regulatory processes,  our results are in 
agreement with the suggestion made by several investigators 
represents the minor antigenic determinant(s) as determined by immuno- 
blot analysis. 
978  Recombinant lO0-kD Nucleolar Polymyositis-Scleroderma  Autoantigen Figure 7.  (a) Indirect  immunofluorescence  on Hep2 cells using rabbit  antibodies  raised against  the expressed cDNA fragment  A. The antibodies 
were affinity purified from the peptide fragment A bound to nitrocellulose  and visualized with a FITC-coupled  goat anti-rabbit IgG antibody.  Im- 
munofluorescence  was observed by epifluorescence optics.  (b) Corresponding phase contrast  image  (x750). 
that the PM/Scl particle is involved in ribosome maturation 
due  to  its  localization  in  the  granular  component  of the 
nudeolus (3, 8), its presence in the nucleoplasm, its absence 
from the cytoplasm, and the apparent migration of nucleolar 
staining  to the nucleoplasm after actinomycin D  treatment 
(4). Previously described proteins found or thought to be in- 
volved in  ribosome biogenesis,  such  as the 40-kD  protein 
ribocharin  (30), a 100-kD protein known as nucleolin (31), 
and a 94-kD protein localized in the dense fibriUar  compo- 
nent of the nucleolus (32), seem to be distinct from the PM/Scl 
proteins. 
One of our main interests, however, was the localization 
of the  antigenic  regions  on the  100-kD  nucleolar  protein. 
Experiments using 15 PM/Scl sera uncovered at least one an- 
tigenic domain between amino  acid residues  153  and 324, 
represented by peptide fragment C. Another minor antigenic 
domain  appears to occur between amino  acid residues 492 
and  703,  as 4  of 15 PM/Scl  sera  immunoreacted  with  the 
peptide fragments  E  and F.  These results are in reasonable 
agreement  with  a  computer-based  analysis  of hydrophilic 
regions on the deduced amino acid sequence of the lO0-kD 
protein.  In this context we would like to point out that the 
experimental  setup used here did not  allow us to uncover 
nonlinear  epitopes. 
Brendel et al.  (33) observed that antigens associated with 
systemic autoimmune diseases possess one of the longest charge 
runs found in proteins sequenced to date (33).  In this con- 
text it is interesting to note that the antigen described here 
possesses two relatively long stretches (amino acid residues 
218-232 and 795-814) of a high density of charged amino acids. 
In summary, we describe the cloning of a 2,797-bp cDNA 
encoding the 100-kD polypeptide of the PM/Scl particle. At 
least one major antigenic determinant is located in the NH2- 
terminal third of the protein. Rabbit antibodies raised against 
a recombinant protein fragment show the same immunolog- 
ical characteristics  as human PM/Scl autoantibodies. The pres- 
ence of a sequence showing a high  homology with a con- 
sensus sequence present  in  several  serine/threonine  kinases 
suggests  a possible function  for the  100-kD  protein. 
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